Category: pharma & healthcare

The Role Of Nucleases In Innate Immune Escape (Part 15)

The nucleases NSP14 and NSP15 seem to form one of the earliest and most troubling defenses the SARS-CoV-2 virus has evolved to defang the innate immune defense.

The Growing Threat Of The Delta Pluses At Home And Abroad

New variants AY.4.2 and AY.33.1 illustrate the dangers of Delta Plus sublineage strains of SARS-CoV-2

Hope For Those Aching Joints

A recent study describes new methods to generate cartilage tissue from stem cells. This is a significant step towards developing innovative treatments for painful joints.

Covid-19 Variation: What Comes Next? The Amazonas Experience

Each successive iteration of SARS-CoV-2 variant to date was more transmissible than the last. New variants drove multiple waves of Covid-19 throughout the world. Here, examine what happened in the past and present of the pandemic in order to understand…

Lateral Flow Tests Detect Most People At Risk Of Transmitting Covid-19

However, a new study has found lateral flow tests are more accurate than previously reported and cannot be compared directly to how PCR tests work.

If Patients Knew: Surgeon Stewardship Versus Balance Sheet Bureaucracy In Orthopaedic Surgery

Rather than treating “value-based care” as a smokescreen to protect profits, we must first align the practice and business of medicine to protect those who know the real value of our care and matter the most: the patient.

Study Finds Children To Be Vectors Of Covid-19 And Emerging Variants

A new study by researchers from Massachusetts General Hospital, Brigham and Women’s Hospital, MIT and Harvard Medical School has found that infants, children and adolescents are equally capable of carrying high levels of live, replicating SARS-CoV-2 in…

Blockchain Technology, A Practical Solution To Vaccine Verification Systems

Though many countries around the world have developed their own vaccine verification systems, often evolved from previous contact tracing apps, developing a reliable, secure and accurate system remains a challenge.

Colin Powell’s Death From Covid-19 Highlights The Need For Boosters And Mitigation To Protect At-Risk Groups

Colin Powell’s death highlights the risks that Covid-19 present to vulnerable groups, such as the elderly and immunocompromised, even if vaccinated. It should serve as a reminder that those at risk ought to get a Covid-19 booster shot as soon as possible.

Colin Powell’s Passing Highlights The Need For More People To Get Vaccinated

Powell’s blood cancer likely reduced the protection he received from Covid-19 vaccination.